Elixir Capital
98.00
+0.72(+0.74%)
Market Cap₹56.92 Cr
PE Ratio6.49
Company Performance:
1D+0.74%
1M-4.39%
6M+23.50%
1Y-12.11%
5Y+127.91%
View Company Insightsright
More news about Elixir Capital
07Apr 26
Elixir Capital Files Newspaper Advertisement for Special Window and Investor Campaign
Elixir Capital Ltd has filed regulatory advertisements announcing two shareholder initiatives: a special window for physical securities transfer running from February 5, 2026 to February 4, 2027, and the Saksham Niveshak campaign from April 1 to July 9, 2026, targeting unpaid dividend claims and KYC updates.
 no imag found
04Apr 26
Sandu Pharmaceuticals Publishes Second 100-Day Campaign Notice for KYC Updates
Sandu Pharmaceuticals Limited has published a newspaper notice regarding the Second 100-Day Campaign 'Saksham Niveshak' for KYC updates and shareholder engagement, following SEBI guidelines. The campaign runs from April 1 to July 9, 2026, with MUFG Intime India Private Limited serving as the Registrar and Transfer Agent to facilitate the process.
 no imag found
20Mar 26
Elixir Capital Subsidiary Faces SEBI Settlement Order Under Algo Platform Scheme
Elixir Capital Limited disclosed that its subsidiary Elixir Equities Private Limited is subject to a SEBI settlement order under the 'Settlement Scheme for Association with Certain Algo Platforms, 2025'. The scheme affects 111 stock brokers, requiring each to pay ₹1,00,000 for alleged violations related to algorithmic trading platforms. The company clarified that the order does not directly impact the listed entity and will not materially affect financial position or operations beyond the settlement amount.
 no imag found
03Feb 26
Elixir Capital Ltd. schedules board meeting for February 13, 2026 to consider Q3FY26 unaudited financial results
Elixir Capital Ltd. has scheduled a board meeting for February 13, 2026, at 4:00 p.m. to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. The company has closed its trading window from January 1, 2026, which will reopen 48 hours after the financial results declaration. This announcement was made in compliance with SEBI (LODR) Regulations, 2015, and communicated to BSE Limited where the company is listed under scrip code 531278.
 no imag found
Elixir Capital
98.00
+0.72
(+0.74%)
1 Year Returns:-12.11%
Industry Peers
Algoquant Fintech
67.51
(+2.24%)
Gyftr
156.79
(-1.49%)
Prime Securities
301.50
(+1.02%)
RNFI Services
303.35
(-2.15%)
Stellant Securities
958.40
(+1.59%)
Akiko Global Services
415.50
(-2.80%)